Buphenine
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 4-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]propyl}phenol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 447-41-6 |
| ATC code | C04AA02 G02CA02 |
| PubChem | CID 4567 |
| ChemSpider | 4407 |
| UNII | 695DKH33EI  |
| ChEMBL | CHEMBL114655 |
| Chemical data | |
| Formula | C19H25NO2 |
| Mol. mass | 299.41 g/mol |
| SMILES | eMolecules & PubChem |
Buphenine (or nylidrin) is a beta-adrenergic agonist[1] that acts as a vasodilator via beta-2 receptors.
[edit] References
- ^ Mittag TW, Tormay A, Messenger M, Podos SM (February 1985). "Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin". Invest. Ophthalmol. Vis. Sci. 26 (2): 163–9. PMID 2857689. http://www.iovs.org/cgi/pmidlookup?view=long&pmid=2857689.
|
|
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
 |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
